Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
A cross-sectional study asked 50 people which of six different models of care would make HIV treatment doable for them.
Two-drug combo of dolutegravir and lamivudine suppresses HIV in newly diagnosed people.
People living with HIV in the U.K. had a much higher risk for heart disease, regardless of age or when they were diagnosed.
The vaccine protects against nine types of human papillomavirus, including those that cause cervical and anal cancer.
Early treatment is linked to a smaller viral reservoir, but blocking IL-10 and PD-1 might control the virus in those with chronic infection.
Little HIV prevention research has included pregnant women for fear of adverse birth outcomes.
While many people who inject drugs could benefit from PrEP, very few take it.
Response to natural SARS-CoV-2 infection suggests HIV-positive people can also respond well to COVID-19 vaccines.
Studies offer reassurance that transgender women can safely and effectively use PrEP with hormone therapy.
I had the privilege of speaking to the good folks at the International AIDS Society about HIV in the 1990s. Check out the podcast!
New analyses show that the long-acting injections may be even more effective than previously reported.
On our third episode, we talk with Dr David Ho, Time’s 1996 Person of the Year and personal doctor to basketball legend Magic Johnson.
Previous studies of the association between tenofovir and the coronavirus have yielded mixed results.
Two new studies come to different conclusions about the risk for severe illness and death.
Ample information, respectful interactions with clinicians and follow-up could be keys to supporting Black women in the South to use PrEP.
The novel HIV capsid inhibitor also shows promise for previously untreated people.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.